Nifurtimox: Clinical Trials

4 trials of Nifurtimox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Unknown 1
Phase 32Completed 1, Unknown 1

Follow Nifurtimox: new trials by email Literature Review of Nifurtimox trials Research Report on Nifurtimox

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
New Therapies and Biomarkers for Chagas Infection
Benznidazole, Nifurtimox - Trypanosoma Cruzi Infection, Chagas Disease
Phase 2CompletedUniversity of Texas, El Paso4502019-12-182024-07-17
CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Nifurtimox, Benznidazole, Placebo - Chagas Disease
Phase 2 / Phase 3UnknownUniversidad Autónoma de Bucaramanga5002015-08-012017-07-21
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases3942012-10-012018-02-20
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Nifurtimox, Cyclophosphamide, Topotecan - Neuroblastoma, Medulloblastoma
Phase 2CompletedGiselle Sholler1122008-01-142024-08-06

Conditions studied

Chagas Disease (2)  ·  Medulloblastoma (1)  ·  Neuroblastoma (1)  ·  Parasitic Diseases (1)  ·  Trypanosomiasis, African (1)

Sponsors

Drugs for Neglected Diseases (1)  ·  Giselle Sholler (1)  ·  Universidad Autónoma de Bucaramanga (1)  ·  University of Texas, El Paso (1)

Countries

Bolivia (1)  ·  Central African Republic (1)  ·  Colombia (1)  ·  Democratic Republic of the Congo (1)  ·  Republic of the Congo (1)  ·  United States (1)

Top investigators

Faustino Torrico, M.D., Ph.D (1)  ·  Giselle Sholler, MD (1)  ·  Igor C Almeida, D.Sc. (1)  ·  Joaquim Gascon, M.D., Ph.D (1)  ·  Juan C Villar, MD, PhD (1)

Results publications

PMID 29113731, PMID 31307503, PMID 34972765, PMID 42772313

NIH funding

U01AI129783 (1)